When the guardian sleeps: Reactivation of the p53 pathway in cancer.

Merkel, O; Taylor, N; Prutsch, N; Staber, PB; Moriggl, R; Turner, SD; Kenner, L MUTAT RES-REV MUTAT. 2017; 773: 1-13.

Distribution and Metabolism of Lipocurc™ (Liposomal Curcumin) in Dog and Human Blood Cells: Species Selectivity and Pharmacokinetic Relevance.

Bolger, GT; Licollari, A; Tan, A; Greil, R; Vcelar, B; Majeed, M; Helson, L; Anticancer Res. 2017; 37(7):348-3492

Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients – AGMT_GASTRIC-3.

Wöll, E; Thaler, J; Keil, F; Gruenberger, B; Hejna, M; Eisterer, W; Fridrik, MA; Ulmer, H; Trommet, V; Huemer, F; Weiss, L; Greil, R; Anticancer Res. 2017; 37(10): 5553-5558.

Improvement of quality of life and psychological distress after inpatient cancer rehabilitation

Riedl, D; Giesinger, JM; Wintner, LM; Loth, FL; Rumpold, G; Greil, R; Nickels, A; Licht, T; Holzner, B WIEN KLIN WOCHENSCHR. 2017; 129(19-20): 692-701.

Transient congenital dilated cardiomyopathy after maternal R-CHOP chemotherapy during pregnancy.

Padberg, S; Mick, I; Frenzel, C; Greil, R; Hilberath, J; Schaefer, C; Reprod Toxicol. 2017; 71: 146-149.

ASCO-update: gastrointestinal tumors.

Weiss, L; Huemer, F; Greil, R; Memo. 2017; 10(4): 240-243.

Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer.

Gampenrieder, SP; Hufnagl, C; Brechelmacher, S; Huemer, F; Hackl, H; Rinnerthaler, G; Romeder, F; Monzo Fuentes, C; Morre, P; Hauser-Kronberger, C; Mlineritsch, B; Greil, R; Pharmacogenomics J. 2017; 17(4):344-350

COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa.

Hainzl, S; Peking, P; Kocher, T; Murauer, EM; Larcher, F; Del Rio, M; Duarte, B; Steiner, M; Klausegger, A; Bauer, JW; Reichelt, J; Koller, U; Mol Ther. 2017; 25(11):2573-2584

Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine – A retrospective single center experience.

Leisch, M; Weiss, L; Lindlbauer, N; Jungbauer, C; Egle, A; Rohde, E; Greil, R; Grabmer, C; Pleyer, L; Leuk Res. 2017; 59:12-19

TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia.

Catakovic, K; Gassner, FJ; Ratswohl, C; Zaborsky, N; Rebhandl, S; Schubert, M; Steiner, M; Gutjahr, JC; Pleyer, L; Egle, A; Hartmann, TN; Greil, R; Geisberger, R; Oncoimmunology. 2017; 7(1):e1371399